Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double – CNBC
Business News
- Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double CNBC
- Novo Nordisk raises 2024 outlook after profit beat fueled by obesity drug demand Yahoo Finance
- Novo Quadruples US Patients Starting Wegovy, Boosts Outlook Bloomberg
- Novo Nordisk now has 130,000 weight-loss prescriptions after boosting supply MarketWatch
- Novo Nordisk raises outlook fuelled by obesity drug demand Reuters
Source: Business News